Literature DB >> 6266305

Calcium channel blockers and Raynaud's disease.

M Vayssairat, L Capron, J N Fiessinger, J F Mathieu, E Housset.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6266305     DOI： 10.7326/0003-4819-95-2-243_2

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  12 in total

Review 1.  Pathogenesis and treatment of Raynaud's phenomenon.

Authors:  J D Coffman
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

Review 2.  Calcium-channel blockers and anaesthesia.

Authors:  P G Durand; J J Lehot; P Foëx
Journal:  Can J Anaesth       Date:  1991-01       Impact factor: 5.063

Review 3.  Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.

Authors:  M M Buckley; S M Grant; K L Goa; D McTavish; E M Sorkin
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 4.  Calcium antagonists in cerebral/peripheral vascular disorders. Current status.

Authors:  K J Tietze; M L Schwartz; P H Vlasses
Journal:  Drugs       Date:  1987-06       Impact factor: 9.546

5.  Limb ischemia caused by small artery disease.

Authors:  J M Porter; L M Taylor
Journal:  World J Surg       Date:  1983-05       Impact factor: 3.352

6.  The peripheral vascular effects of diltiazem--dose-response characteristics.

Authors:  M B Finch; G D Johnston
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

Review 7.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

Review 8.  Management of Raynaud's phenomenon. Focus on newer treatments.

Authors:  S Roath
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 9.  Choosing the correct drug for the individual hypertensive patient.

Authors:  L H Opie
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 10.  Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.